| Document |
Document Title |
|
WO/2017/135184A1 |
[Problem] To provide a method for depolymerizing a polycondensate of 2-cyanoacrylate at a low temperature in a short time and obtaining high-purity 2-cyanoacrylate. [Solution] A method for producing 2-cyanoacrylate, said method being cha...
|
|
WO/2017/130906A1 |
Provided is a fluid bed ammoxidation reaction catalyst which includes silica and a metal oxide, and in which a composite of the silica and the metal oxide is represented by general formula (1), namely Mo12BiaFebNicCodCeeCrfXgOh/(SiO2)A (...
|
|
WO/2017/130909A1 |
Provided is a fluid bed ammoxidation reaction catalyst which includes silica and a metal oxide, and in which a composite of the silica and the metal oxide is represented by general formula (1), namely Mo12BiaFebNicMgdCoeCefCrgZnhXiOj/(Si...
|
|
WO/2017/121022A1 |
An integrated purification method and an integrated purification system for an industrial waste gas containing cyanides, hydrocarbons and NOx. Said method comprises the steps of: 1) a tail gas containing pollutants of cyanides, hydrocarb...
|
|
WO/2017/119633A1 |
The present invention relates to a polymer structure produced using gaseous molecular layer deposition and cleavable by an external stimulus. The polymer structure according to one embodiment of the present invention comprises a base mem...
|
|
WO/2017/107939A1 |
Disclosed is a malononitrile oxime ether compound having a novel structure as shown in the general formula I. Respective substituents in the general formula I are as defined in the specification. The compound of the general formula I exh...
|
|
WO/2017/105831A1 |
A process for separating acrylonitrile from a mixture of acrylonitrile and acetonitrile includes providing a mixture of acrylonitrile and acetonitrile to a recovery column; contacting the mixture of acrylonitrile and acetonitrile with aq...
|
|
WO/2017/106552A1 |
Proteins of methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic sensor/signal transducer, are phosphorylated on exposure to β-lactam antibiotics. This event is critical for the onset of the biochemical events that unleash ...
|
|
WO/2017/105820A1 |
A process for separating acrylonitrile from a mixture of acrylonitrile and acetonitrile includes providing a mixture of acrylonitrile and acetonitrile to a recovery column; contacting the mixture of acrylonitrile and acetonitrile with aq...
|
|
WO/2017/103942A1 |
The present invention relates to an improved process for the preparation of Teriflunomide with high yield and high purity. The present invention also relates to a process for the preparation of teriflunomide which is free from genotoxic ...
|
|
WO/2017/101791A1 |
Disclosed are a compound and a use thereof in preparing a drug, and in particular, provided in the present invention are: the compound as shown in formula (I) or a stereoisomer, a geometric isomer, a tautomer, a racemate, a nitroxide, a ...
|
|
WO/2017/105803A1 |
An extractive distillation process includes providing a mixture that includes acrylonitrile and acetonitrile to at least one distillation column; contacting the mixture that includes acrylonitrile and acetonitrile with aqueous solvent to...
|
|
WO/2017/097884A1 |
The present invention refers to substituted cyclopentyl- and cyclohexyl-derivatives of formula (I) wherein n, R1, R2, R3, R4 and X have the same meaning as given in the description. The invention further refers to fragrance compositions ...
|
|
WO/2017/095177A2 |
The present application can provide a phthalonitrile compound and a use thereof. The phthalonitrile compound has a novel structure, and can exhibit an excellent effect in a use to which the phthalonitrile compound can be applied. An exam...
|
|
WO/2017/096210A1 |
In one embodiment, the present invention provides a method, comprising: a. adding an effective amount of at least one compound selected from the group consisting of a substituted catechol, nitroxide free radicals, a compound of Formula 2...
|
|
WO/2017/093149A1 |
The present invention refers to processes for catalytic reversible alkene-nitrile interconversion through controllable HCN-free transfer hydrocyanation.
|
|
WO/2017/090621A1 |
Provided is a method for producing a diol having a specific structure with high yield while keeping high selectivity. A method for producing a diol having a specific structure by oxidizing an olefin having a specific structure in the pre...
|
|
WO/2017/086713A1 |
The present application relates to a compound and an organic electronic element comprising the same.
|
|
WO/2017/087175A1 |
A process and system for acrylonitrile and HCN recovery includes a heads column system operated to reduce heads column condenser duty and reduce equipment while maintaining required purity and specifications with minimal increases in reb...
|
|
WO/2017/076992A1 |
The invention concerns new regulator compounds for a novel polymerization process for vinyl monomers, which yields polymers with improved control over composition and nearly full to full conservation of architectural integrity up to high...
|
|
WO/2017/075531A1 |
Compounds are provided having the following structure: (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, L1, L2, G1, G2 and G3 are as defined herein. Use of the compounds as a component of l...
|
|
WO/2017/073934A1 |
The present specification provides a polycyclic compound of chemical formula 1, and an organic light emitting device comprising the same.
|
|
WO/2017/072038A1 |
A method for synthesizing 2-alkyl-4-trifluoromethyl-3-alkylsulfonyl-benzoic acids of formula (I) is described. In said formula (I), the substituents represent groups such as alkyl and substituted phenyl (formulae (II)-(V), (V)-(I)).
|
|
WO/2017/069995A1 |
A catalytic composition useful for the conversion of an olefin selected from the group consisting of propylene, isobutylene or mixtures thereof, to acrylonitrile, methacrylonitrile, and mixtures thereof, or acrolein/arylic acid, methacro...
|
|
WO/2017/069210A1 |
Provided is an organic electroluminescent element that has, in order, an anode, a hole injection layer, a hole transport layer, a light emission layer, and a cathode, wherein the hole transport layer includes a compound represented by fo...
|
|
WO/2017/069058A1 |
Provided is an electrolytic solution with which it is possible to obtain a module or an electrochemical device such as a lithium-ion secondary cell in which generation of gas is less likely to occur even when stored in a high temperature...
|
|
WO/2017/052323A1 |
The present application can provide a phthalonitrile compound and a use thereof. The present application can provide a phthalonitrile compound capable of forming a phthalonitrile resin by self-curing or of serving as a curing agent after...
|
|
WO/2017/050092A1 |
Provided is a method for preparing an intermediate of formula II for odanacatib, comprising a step of reducing the compound of formula II to a compound of formula IA, wherein the reduction is performed by adding a metal chloride and a me...
|
|
WO/2017/049172A1 |
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of condi...
|
|
WO/2017/047807A1 |
The present invention addresses the problem of searching for a compound which can be provided at a terminal of a peptide nucleic acid that is effective for the detection of a single nucleotide polymorphism. Provided is a tolan compound r...
|
|
WO/2017/042514A1 |
The present invention relates to a compound of formula (I): in which: - the R1 and R2 groups, which may be identical or different, are, independently of one another, a saturated or unsaturated, linear, branched or cyclic hydrocarbon grou...
|
|
WO/2017/041642A1 |
Provided is a compound based on a meta-linked bihydrazinoazine structure and a preparation method and a use thereof. The compound can be used as a red probe and has an excellent aggregation-induced luminescence property, and can be used ...
|
|
WO/2017/040583A1 |
Disclosed is a method for inhibiting the formation of by-products from dinitriles, such as the formation of cyclopentylideneimine (CPI) from Adiponitrile (ADN), comprising adding an effective amount of a Brønsted acid to the ADN. Also d...
|
|
WO/2017/036357A1 |
Provided are a cathepsin K inhibitor and application thereof, and specifically is a compound having a structure represented by formula (I) and being used to treat or prevent a cathepsin dependent disease. In particular, the cathepsin is ...
|
|
WO/2017/040518A1 |
A method for etching silicon-containing films is disclosed. The method includes the steps of introducing a vapor of a nitrogen containing etching compound into a reaction chamber containing a silicon-containing film on a substrate, where...
|
|
WO/2017/031871A1 |
Provided is a method for preparing 1,3,6-hexanetricarbonitrile, comprising the following steps: A. preparation of 1,6-dicyano-2-butylene; and B. preparation of the 1,3,6-hexanetricarbonitrile. Provided is a new method for preparing 1,3,6...
|
|
WO/2017/028472A1 |
Provided are a new aromatic cyanogen compound and a preparation method thereof. The present invention also relates to the use of such compound in antiviral drugs, in particular the use thereof in anti-HCV drugs.
|
|
WO/2017/026298A1 |
The present invention addresses the problem of providing a compound which can exhibit an excellent controlling effect against harmful arthropods. The problem can be solved by an oxalyl amide compound represented by formula (I) [wherein G...
|
|
WO/2017/024703A1 |
The present invention provides an aromatic amine compound comprising a structure of formula (I). The compound provided according to the invention has luminous efficacy, which will result in, when in a condition of a current density of 20...
|
|
WO/2017/015521A1 |
Disclosed is a process for co-manufacture of ACRN and HCN with improved HCN selectivity and reduced solids formation in a shared product recovery section.
|
|
WO/2017/009753A1 |
The present invention provides an improved process for the preparation of 3-(4-chlorophenyl)-3- cyanopropanoic acid (compound (A)) and further its transformation to Baclofen (I). The process comprises reaction of compound (II) with Glyox...
|
|
WO/2017/009866A1 |
Disclosed herein is a novel recovery and recycling process of racemic 4-(4- dimethylamino)-1-(4'-fluorophenyl)-1-(hydroxybutyl)-3-(hydro
xymethyl)- benzonitrile (hereinafter referred as cyanodiol). The racemic cyanodiol is an intermediat...
|
|
WO/2017/010438A1 |
Provided is an organic electroluminescence element having a positive electrode, a negative electrode, a light-emitting layer that is included between the positive electrode and the negative electrode, and a hole transport layer that is i...
|
|
WO/2017/006929A1 |
The present invention makes it easy to obtain, with good yield and stereoselectivity, an optically active α-tetrasubstituted α-amino nitrile derivative, or an intermediate for the synthesis of said derivative, by reacting a cyanometala...
|
|
WO/2017/002849A1 |
The present invention provides a method for producing a 3-cyanopyrrole compound that is useful as an intermediate for pharmaceutical products. A method for producing a compound (II), which comprises subjecting a compound (I) to a reducti...
|
|
WO/2016/207158A1 |
The invention relates to aromatic 4,6-bis-trichloromethyl-s-triazin-2-yl- compounds of formula (I), a method for producing para disubstituted benzoic acid nitriles as a precursor to compounds of formula (I), and a method for producing same.
|
|
WO/2016/206573A1 |
The invention provides compounds that inhibit FTO (fat mass and obesity), including pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making a...
|
|
WO/2016/203410A1 |
The present invention provides a process for the preparation of Teriflunomide (Formula-I). The present invention describes the synthesis of Teriflunomide without isolating the intermediate Leflunomide. Teriflunomide is prepared from 5-Me...
|
|
WO/2016/197320A1 |
The present invention relates to a method for preparing a Citalopram glycol intermediate represented by formula IV. The method comprises the following steps: in the existence of an auxiliary reagent metal salt, allowing 5-cyanophthalide ...
|
|
WO/2016/191855A1 |
The present invention relates to diene nitrile compounds with anti-convulsant activity and can also be used to treat pain. These compounds are useful in modulating voltage-gated sodium channel activity and can be used in the treatment of...
|
